Insider Trading Activity Second Sight Medical Products, Inc. – Director Bought 17,020 shares of Stock

0

Insider Trading Activity For Second Sight Medical Products, Inc.

Gregg Williams , Director of Second Sight Medical Products, Inc. reportedly Bought 17,020 shares of the company’s stock at an average price of 1.18 for a total transaction amount of $20,083.60 SEC Form

Insider Trading History For Second Sight Medical Products, Inc.

  • On 11/19/2014 Gregg Williams, Director, bought 111,111 with an average share price of $9.00 per share and the total transaction amounting to $999,999.00.View SEC Filing
  • On 3/23/2015 Robert J Greenberg, CEO, sold 100,000 with an average share price of $13.28 per share and the total transaction amounting to $1,328,000.00.View SEC Filing
  • On 5/27/2015 Anne-Marie Juliette Ripley, VP, sold 45,629 with an average share price of $13.04 per share and the total transaction amounting to $595,002.16.View SEC Filing
  • On 6/3/2015 Robert J Greenberg, CEO, sold 150,000 with an average share price of $14.04 per share and the total transaction amounting to $2,106,000.00.View SEC Filing
  • On 6/4/2015 Anne-Marie Juliette Ripley, VP, sold 4,371 with an average share price of $15.00 per share and the total transaction amounting to $65,565.00.View SEC Filing
  • On 12/4/2015 Anne-Marie Juliette Ripley, VP, sold 2,500 with an average share price of $5.50 per share and the total transaction amounting to $13,750.00.View SEC Filing
  • On 12/7/2015 Robert J. Greenberg, Chairman, sold 17,969 with an average share price of $5.30 per share and the total transaction amounting to $95,235.70.View SEC Filing
  • Analyst Ratings For Second Sight Medical Products, Inc.
    These are 0 Sell Ratings, 0 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings .
    The current consensus rating for Second Sight Medical Products, Inc. is Buy (Score: 3.00) with a consensus target price of $5.00 , a potential (338.60% upside)

    Analyst Ratings History For Second Sight Medical Products, Inc.

    • On 7/26/2016 Rodman & Renshaw Reiterated Rating Buy with a price target of $16.00
    • On 11/6/2017 HC Wainwright Reiterated Rating Buy with a price target of $5.00

    Recent Trading Activity for Second Sight Medical Products, Inc.
    Shares of Second Sight Medical Products, Inc. closed the previous trading session at with shares trading hands.

    An ad to help with our costs